Georgia Healthcare Group PLC Notice of Results (2623X)

TIDMGHG

RNS Number : 2623X

Georgia Healthcare Group PLC

09 August 2018

London, 9 August 2018

Georgia Healthcare Group PLC notice of 2Q and 1H 2018 Results

Georgia Healthcare Group PLC ("GHG") will publish its financial results for 2Q and 1H 2018 at 07:00 London time on Wednesday, 15 August 2018. The results announcement will be available on GHG's website at ghg.com.ge. An investor/analyst conference call, organised by GHG, will be held on Wednesday, 15 August 2018, at 14:00 UK / 15:00 CET / 09:00 U.S Eastern Time. The duration of the call will be 60 minutes and will consist of a 15-minute update and a 45-minute Q&A session.

 
 Dial-in numbers:                      30-Day replay 
 Pass code for replays / conference    Pass code for replays / conference 
  ID: 4799588                           ID: 4799588 
 International Dial in: +44 (0) 2071   International Dial in: +44 (0) 
  928000                                3333 00 97 85 
 UK: 08445718892                       UK National Dial in: 08717000471 
 US: 16315107495                       UK Local Dial in: 08445718951 
 Austria: 019286559                    US Free Call Dial in: 1 (917) 677 
                                        7532 
 Belgium: 024009874 
 Czech Republic: 228881424 
 Finland: 0942450806 
 France: 0176700794 
 Germany: 06924437351 
 Ireland: 014319615 
 Italy: 0687502026 
 Netherlands: 0207143545 
 Norway: 23960264 
 Spain: 914146280 
 Sweden: 0850692180 
 Switzerland: 0315800059 
 

Name of authorised official of issuer responsible for making notification:

Ketevan Kalandarishvili, Head of Investor Relations

About Georgia Healthcare Group PLC

Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 37 hospitals and 17 district polyclinics. GHG is the single largest market participant, accounting for 26.4% of total hospital bed capacity in the country, as of 31 March 2018. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 30% market share by revenue. GHG is the second largest provider of medical insurance in Georgia with a 27.9% market share based on net insurance premiums earned and approximately 159,000 insurance customers as at March 2018. GHG employed a total of c.15,500 people as at 31 March 2018, including c.3,600 physicians.

For further information, please visit ghg.com.ge or contact:

 
      Nikoloz Gamkrelidze            Irakli Gogia                      Ketevan Kalandarishvili 
      CEO                            CFO                               Head of Investor 
                                                                        Relations 
                                                                          [phone] 
      [phone] (5077)             [phone] (5088)            (5079) 
      [e-mail]            [e-mail]            [e-mail] 
 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NORDVLFBVVFFBBL

(END) Dow Jones Newswires

August 09, 2018 02:01 ET (06:01 GMT)